Jump to navigation
STEM CELLS | STEM CELLS Translational Medicine
Trial provides evidence for the safety and feasibility of cord blood cell infusion after birth in preterm neonates to reduce the rate of complications
Successful pre‐clinical studies in animal models heralded the increasing clinical interest of cord blood in regenerative therapy.
A recent STEM CELLS Translational Medicine article reporting on a prospective non-r
Intraventricular hemorrhage (IVH), a severe complication of preterm birth leading to hydrocephalus, cerebral palsy, and mental retardation, suffers from a lack of therapeutic approaches.
Early intravenous infusion of umbilical cord stem cells fosters long‐term improvements in tissue and functional readouts following spinal cord injury
A new study reports the results of a trial comparing intra‐articular injection of umbilical cord MSCs for the treatment of human knee osteoarthritis
A study reports on the factors controlling improved platelet engraftment of umbilical cord blood progenitors by osteoblast conditioned medium treatment
The development of squamous cell carcinoma in patients suffering from recessive dystrophic epidermolysis bullosa may be suppressed by cord blood‐derived stem cells
The first human trial of human umbilical cord blood‐derived MSCs in rheumatoid arthritis patients suggest safety and efficacy of a single intravenous infusion
Researchers report how paracrine signaling from umbilical cord stem and progenitor cells can promote the healing of diabetes-associated skin wounds
The Stem Cells Portal is a shared platform for the STEM CELLS and STEM CELLS Translational Medicine sister journals, providing up-to-the-minute coverage of the latest research from bench science and developments to clinical applications.
Copyright © 2020